BE902875A - Inhibition du syndrome de radiation aigu avec une endotoxine detoxifiee raffinee - Google Patents

Inhibition du syndrome de radiation aigu avec une endotoxine detoxifiee raffinee

Info

Publication number
BE902875A
BE902875A BE0/215338A BE215338A BE902875A BE 902875 A BE902875 A BE 902875A BE 0/215338 A BE0/215338 A BE 0/215338A BE 215338 A BE215338 A BE 215338A BE 902875 A BE902875 A BE 902875A
Authority
BE
Belgium
Prior art keywords
warm
acute radiation
radiation syndrome
blooded animal
inhibition
Prior art date
Application number
BE0/215338A
Other languages
English (en)
French (fr)
Inventor
E E Ribi
Original Assignee
Ribi Immunochem Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ribi Immunochem Research Inc filed Critical Ribi Immunochem Research Inc
Publication of BE902875A publication Critical patent/BE902875A/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
BE0/215338A 1984-07-12 1985-07-12 Inhibition du syndrome de radiation aigu avec une endotoxine detoxifiee raffinee BE902875A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/630,013 US4629722A (en) 1984-07-12 1984-07-12 Method of inhibiting the onset of acute radiation syndrome

Publications (1)

Publication Number Publication Date
BE902875A true BE902875A (fr) 1985-11-04

Family

ID=24525404

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/215338A BE902875A (fr) 1984-07-12 1985-07-12 Inhibition du syndrome de radiation aigu avec une endotoxine detoxifiee raffinee

Country Status (14)

Country Link
US (1) US4629722A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
JP (1) JPS6193123A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
KR (1) KR880000191B1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
AU (1) AU556971B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
BE (1) BE902875A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
CH (1) CH665355A5 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
DE (2) DE3524992A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
FR (1) FR2567403A1 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
GB (1) GB2161381B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IL (1) IL75789A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
IT (1) IT1214671B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NL (1) NL8501995A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
NZ (1) NZ212691A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)
ZA (1) ZA855243B (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530113A (en) * 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
US5612476A (en) * 1991-10-11 1997-03-18 Eisai Co., Ltd. Anti-endotoxin compounds

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4866034A (en) * 1982-05-26 1989-09-12 Ribi Immunochem Research Inc. Refined detoxified endotoxin
US5354782A (en) * 1991-01-17 1994-10-11 Merrell Dow Pharmaceuticals Inc. Polyamine phenols as radioprotective agents
US6218166B1 (en) 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
US20090181078A1 (en) 2006-09-26 2009-07-16 Infectious Disease Research Institute Vaccine composition containing synthetic adjuvant
AU2007354917B2 (en) 2006-09-26 2013-06-06 Access To Advanced Health Institute Vaccine composition containing synthetic adjuvant
TWI494125B (zh) 2009-06-05 2015-08-01 Infectious Disease Res Inst 合成的葡萄吡喃糖基脂質佐劑
NZ616304A (en) 2011-04-08 2016-01-29 Immune Design Corp Immunogenic compositions and methods of using the compositions for inducing humoral and cellular immune responses
AU2013262691B2 (en) 2012-05-16 2018-12-20 Immune Design Corp. Vaccines for HSV-2
WO2017039751A1 (en) 2015-08-28 2017-03-09 Bioincept, Llc Mutant peptides and methods of treating subjects using the same
SG11201508092YA (en) 2013-04-18 2015-10-29 Immune Design Corp Gla monotherapy for use in cancer treatment
US9463198B2 (en) 2013-06-04 2016-10-11 Infectious Disease Research Institute Compositions and methods for reducing or preventing metastasis
CA2961375A1 (en) * 2014-09-16 2016-03-24 Bioincept, Llc Compositions and methods for treating acute radiation syndrome
EP3341006A4 (en) 2015-08-28 2019-03-13 BioIncept LLC COMPOSITIONS AND METHODS FOR TREATING NERVE DAMAGE
KR101909660B1 (ko) * 2017-07-06 2018-10-18 이보미 안경알 자판기 서비스 제공 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1188519A (en) * 1966-10-27 1970-04-15 Wellcome Found Method for the Purification of Lipopolysaccharides
US4435386A (en) * 1982-05-26 1984-03-06 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
US4436728A (en) * 1982-05-26 1984-03-13 Ribi Immunochem Research, Inc. Refined detoxified endotoxin product
CA1225592A (en) * 1983-08-26 1987-08-18 Ribi Immunochem Research Inc. Refined detoxified endotoxin

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5530113A (en) * 1991-10-11 1996-06-25 Eisai Co., Ltd. Anti-endotoxin compounds
US5612476A (en) * 1991-10-11 1997-03-18 Eisai Co., Ltd. Anti-endotoxin compounds
US5756718A (en) * 1991-10-11 1998-05-26 Eisai Co., Ltd. Anti-endotoxin compounds
US5843918A (en) * 1991-10-11 1998-12-01 Eisai Co., Ltd. Anti-endotoxin compounds

Also Published As

Publication number Publication date
GB2161381A (en) 1986-01-15
DE3546592C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-06-01
IL75789A0 (en) 1985-11-29
US4629722A (en) 1986-12-16
AU4475885A (en) 1986-01-16
FR2567403A1 (fr) 1986-01-17
IL75789A (en) 1990-04-29
AU556971B2 (en) 1986-11-27
KR860000867A (ko) 1986-02-20
NL8501995A (nl) 1986-02-03
NZ212691A (en) 1988-02-12
CH665355A5 (de) 1988-05-13
IT8548347A0 (it) 1985-07-12
GB8517545D0 (en) 1985-08-14
KR880000191B1 (ko) 1988-03-12
IT1214671B (it) 1990-01-18
JPS6234733B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1987-07-28
GB2161381B (en) 1988-01-13
DE3524992C2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) 1988-05-11
ZA855243B (en) 1986-02-26
JPS6193123A (ja) 1986-05-12
DE3524992A1 (de) 1986-01-16

Similar Documents

Publication Publication Date Title
BE902875A (fr) Inhibition du syndrome de radiation aigu avec une endotoxine detoxifiee raffinee
WO1997039759A3 (en) Omega-3 fatty acids and omega-3 phosphatidylcholine in the treatment of bipolar disorder
KR920700200A (ko) 19-노르-비타민 d 화합물
BE902874A (fr) Compositions therapeutiques et procede pour le traitement ou la prevention des maladies provoquees par le paf-acether
KR940018089A (ko) 내부조직의 방사선 손상에 대한 예방 및 처치방법
ES2095772T3 (es) Utilizacion de derivados de rifamicina para producir un medicamento destinado al tratamiento de la toxoplasmosis.
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
AU555093B2 (en) Calcium-antagonist composition
ES429585A1 (es) Procedimiento de preparacion de un alcanol superior.
SE8303003L (sv) Medel for att oka antitumorverkan hos antitumormedel
MX9300204A (es) Composicion farmaceutica que contiene azauridina para el tratamiento de la artritis reumatoide.
FR2375865A1 (fr) Compositions medicamenteuses contenant des sterolines et leurs applications therapeutiques
KR890006227A (ko) 페놀-함유 진해성 액체 조성물
MD940152A (ro) Compoziţie farmaceutică pentru tratarea infecţiilor şi bolilor, provocate de virusul hepatitei V (HBV)
EP0088462A3 (en) Anti-inflammatory and rheumatic composition containing organophosphonate and steroid
MY8700934A (en) Pharmaceutical compositions comprising 7,8-dihydroxy-i(hydroxyphenyl)-2,3,4,5-tetrahydro-ih-3-benzazepine derivatives and a beta-adrenergic blocking compound
KR900700448A (ko) 불포화 측쇄를 갖는 1α-히드로시비타민 D동족체
IE821855L (en) Glycerophosphocholines
KR880004810A (ko) 소화성 궤양 치료제
KR870011135A (ko) 시스-6-(4-아세트아닐리도)-8,9-디메톡시-2-메틸-1,2,3,4,4a,10b- 헥사이드로-벤조〔c〕〔1,6〕 나프티리딘으로 구성된 약학적 조성물 및 그것의 용도
KR830009776A (ko) 세포 보호 유도방법
KR900701273A (ko) 진토성 에르골린 유도체
NO962503L (no) Anvendelse av penoksyfyllin ved behandling av multippel sklerose
SE8206728D0 (sv) Lekemedelspreparat
KR890007737A (ko) 진토작용을 하는 약제

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: RIBI IMMUNOCHEM RESEARCH INC.

Effective date: 19980731